Neuronetics
STIM • NASDAQ
Neuronetics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Daniel L. Reuvers, with a market cap of $95.6M.
Market Cap$95.6M
Employees202.0
CEODaniel L. Reuvers
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Neuronetics FAQ
Common questions about Neuronetics
Neuronetics is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $34.2M.
Neuronetics has approximately 202 employees.